STAT Plus: Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial – Boston, Massachusetts

Boston, Massachusetts 2020-09-24 09:27:11 –

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite gloomy skies that can be seen from our window. And why not? Keep on the sunny side, as they say. Moreover, our rambunctious official mascot is happily snoozing at our feet. A rare respite from the usual noisy friskiness, which is to say we can get more work done. In fact, here are a few tidbits to help your morning move along. Let us now raise a cup of stimulation to another interesting and productive day. And of course, do keep in touch. …

Most Americans have never heard of Dr. Richard Whitley, an expert in pediatric infectious diseases at the University of Alabama-Birmingham, but as the pandemic drags on and the public eagerly awaits a vaccine, he may well be among the most powerful people in the country, Kaiser Health News says. Whitley leads a small, secret panel of experts tasked with reviewing safety and effectiveness data of Covid-19 vaccines that U.S. taxpayers helped fund. The data and safety monitoring board also has the power to halt a clinical trial or fast-track it.

Continue to STAT Plus to read the full story…

Source link

Back to top button